Correlation Between Salesforce and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Salesforce and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and SAB Biotherapeutics, you can compare the effects of market volatilities on Salesforce and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and SAB Biotherapeutics.
Diversification Opportunities for Salesforce and SAB Biotherapeutics
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Salesforce and SAB is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Salesforce i.e., Salesforce and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Salesforce and SAB Biotherapeutics
Considering the 90-day investment horizon Salesforce is expected to generate 0.27 times more return on investment than SAB Biotherapeutics. However, Salesforce is 3.75 times less risky than SAB Biotherapeutics. It trades about 0.1 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.0 per unit of risk. If you would invest 13,334 in Salesforce on August 24, 2024 and sell it today you would earn a total of 20,448 from holding Salesforce or generate 153.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Salesforce vs. SAB Biotherapeutics
Performance |
| Timeline |
| Salesforce |
| SAB Biotherapeutics |
Salesforce and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and SAB Biotherapeutics
The main advantage of trading using opposite Salesforce and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify | Salesforce vs. Workday |
| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |